Microcoat now offering Assay Development and Sample Measurement on MSD® Platform

Microcoat expands its technological portfolio by Meso Scale Discovery´s Electrochemiluminescence (MSD-ECL) platform. Based on non-radioactive electrochemiluminescent labels for ultra-sensitive detection, MSD yields higher sensitivity and broader dynamic range compared to ELISA technology. Microcoat offers development of assays from the scratch as well as transfer of classical ELISA formats in addition to method comparison, validation and sample measurement. Customers profit from our year-long experience in custom-fit optimization and manufacturing of antibody conjugates including MSD´s SULFO-Tag®.
MORE NEWS
- 17Dez.
Sneak peek at the upcoming events – 2026
Read More → - 17Dez.
Button Lottery PharmaLab 2025
Read More → - 19Nov.
Microcoat announces the 13th Monocyte-Activation Test Proficiency Test Program
Read More → - 03Nov.
Meet Microcoat at the PharmaLab Congress 2025!
Read More → - 15Okt.
Meet Microcoat at the PDA Pyrogens Workshop 2025!
Read More → - 17Sep.
We are looking forward to an exciting conference season 2025
Read More → - 17Sep.
Meet Microcoat at the 47th ISOBM Conference 2025
Read More → - 17Sep.
Meet us at Olink Biomarker Seminar 2025
Read More → - 28Mai
Microcoat announces the 12th Monocyte-Activation Test Proficiency Test Program
Read More → - 20Mai
We’re part of the IHK ÜBERnehmer campaign!
Read More →







